The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Acadia Healthcare Company Inc (NASDAQ: ACHC) was $13.23 for the day, down -2.22% from the previous closing price of $13.53. In other words, the price has decreased by -$2.22 from its previous closing price. On the day, 2.23 million shares were traded. ACHC stock price reached its highest trading level at $13.6 during the session, while it also had its lowest trading level at $12.99.
Ratios:
Our analysis of ACHC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.43 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.76.
On December 03, 2025, BofA Securities Downgraded its rating to Underperform which previously was Neutral but kept the price unchanged to $13.
BofA Securities Downgraded its Buy to Neutral on September 10, 2025, while the target price for the stock was maintained at $25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 1196577536 and an Enterprise Value of 3722060544. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.22, and their Forward P/E ratio for the next fiscal year is 6.83. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.37 while its Price-to-Book (P/B) ratio in mrq is 0.38. Its current Enterprise Value per Revenue stands at 1.14 whereas that against EBITDA is 5.938.
Stock Price History:
The Beta on a monthly basis for ACHC is 0.89, which has changed by -0.69506425 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, ACHC has reached a high of $47.08, while it has fallen to a 52-week low of $12.63. The 50-Day Moving Average of the stock is -16.42%, while the 200-Day Moving Average is calculated to be -38.41%.
Shares Statistics:
ACHC traded an average of 2.75M shares per day over the past three months and 2542170 shares per day over the past ten days. A total of 90.43M shares are outstanding, with a floating share count of 89.34M. Insiders hold about 3.16% of the company’s shares, while institutions hold 124.62% stake in the company. Shares short for ACHC as of 1767139200 were 19412833 with a Short Ratio of 7.07, compared to 1764288000 on 14473235. Therefore, it implies a Short% of Shares Outstanding of 19412833 and a Short% of Float of 25.019999999999996.
Earnings Estimates
The market rating for Acadia Healthcare Company Inc (ACHC) is a result of the insights provided by 11.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.32, with high estimates of $0.46 and low estimates of $0.19.
Analysts are recommending an EPS of between $2.38 and $1.94 for the fiscal current year, implying an average EPS of $2.08. EPS for the following year is $1.93, with 12.0 analysts recommending between $2.45 and $1.48.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 11 analysts. It ranges from a high estimate of $827.18M to a low estimate of $795.8M. As of. The current estimate, Acadia Healthcare Company Inc’s year-ago sales were $774.24MFor the next quarter, 11 analysts are estimating revenue of $815.15M. There is a high estimate of $835.1M for the next quarter, whereas the lowest estimate is $795.4M.
A total of 11 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.32B, while the lowest revenue estimate was $3.29B, resulting in an average revenue estimate of $3.29B. In the same quarter a year ago, actual revenue was $3.15BBased on 11 analysts’ estimates, the company’s revenue will be $3.44B in the next fiscal year. The high estimate is $3.48B and the low estimate is $3.39B.
